We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Clarify Regulatory Status of Cannabidiol, Abernethy Says
FDA to Clarify Regulatory Status of Cannabidiol, Abernethy Says
FDA Principal Deputy Commissioner Amy Abernethy announced on Tuesday that the agency will clarify its regulatory approach to cannabidiol products in light of the increasing illegal marketing of CBD products as FDA approved.